Shares of Centene Corp (NYSE: CNC) shot up over 3% on average volume on Friday, after it was revealed that activist investor and CEO of asset management firm Third Point, Daniel Seth Loeb, has sought for the company’s sale.
According to The Wall Street Journal, Third Point holds at least a $300 million worth of stake in the insurance firm.
Loeb reportedly wants Centene to sell itself before it consummates the deal to buy WellCare Health Plans (NYSE: WCG) for $15.3 billion. The deal was announced in March this year, and both the companies are set to have shareholder meetings next month to sort out differences and go forward with the deal.
READ: WHAT YOU NEED TO KNOW BEFORE BUYING VILLAGE FARMS STOCK
Other activist investors including Corvex Management and Sachem Head Capital Management had also earlier put forward similar demands.
However, earlier this month, Centene chief Michael Neidorff said in a letter that the deal was under regulatory process and they are planning to go ahead with it.
Shares of health insurers Humana (NYSE: HUM) and UnitedHealth Group (NYSE: UNH) also spiked during intra-day trading on the likelihood of being a potential match to Centene. Shares of WellCare Health, meanwhile, fell into the red zone.
Most Popular
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Target (TGT): A look at some of the challenges faced by the retailer in 3Q24
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and